HIMS vs TDOC Comparison: AI Score, Valuation, Performance and Upside
Compare Hims & Hers and Teladoc by GLP-1 weight loss momentum, subscription vs enterprise revenue model, customer acquisition cost, margin trajectory, and which digital health platform offers better long-term upside.
Use this Hims & Hers vs Teladoc comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.
HIMS holds the edge across 3 of 5 key metrics in this comparison. TDOC has delivered stronger 1-year price return (+6.95% vs -50.99%), though HIMS has the better forward P/E setup (21.53x vs -13.54x for TDOC). Analyst consensus implies meaningfully more upside for HIMS (+5.98%) than for TDOC (-9.08%).
| Metric | HIMS | TDOC |
|---|---|---|
| AI score | 35.8 | 24.1 |
| AI rank | #1604 | #3275 |
| Latest close | $28.09 | $8.77 |
| 1M return | -14.10% | +12.29% |
| 6M return | -7.96% | +38.11% |
| 1Y return | -50.99% | +6.95% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | HIMS | TDOC |
|---|---|---|
| 1Y ago | $4.9K (-51.0%) started 2025-07-24 | $10.7K (+7.0%) started 2025-07-24 |
| 5Y ago | $34.3K (+243.0%) started 2021-07-26 | $585.64 (-94.1%) started 2021-07-26 |
| 10Y ago | $28.66K (+186.6%) started 2019-09-13 | $5.02K (-49.8%) started 2016-07-25 |
Hypothetical — past performance does not guarantee future results.
| Metric | HIMS | TDOC |
|---|---|---|
| Market cap | $6.5B | $1.58B |
| Trailing P/E | N/A | N/A |
| Forward P/E | 21.53 | -13.54 |
| Price/Sales | 2.74 | 0.63 |
| EV/Revenue | 3.36 | 0.74 |
| Analyst target | $29.77 | $7.97 |
| Target upside | +5.98% | -9.08% |
| Metric | HIMS | TDOC |
|---|---|---|
| Revenue growth | 3.80% | -2.50% |
| Earnings growth | N/A | N/A |
| EPS growth | N/A | N/A |
| FCF margin | +7.36% | +8.28% |
| Operating margin | N/A | N/A |
| Profit margin | -0.56% | -6.81% |
| ROIC proxy | -2.66% | -12.39% |
| Return on equity | -2.66% | -12.39% |
| Dividend yield | 0.00% | 0.00% |
| Beta | 2.34 | 2.10 |
| Debt/equity | 253.72 | 77.68 |
| Current ratio | 1.69 | 2.80 |
| Quick ratio | 1.46 | 2.40 |
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | HIMS | TDOC |
|---|---|---|---|
| 1Y | Growth | -50.99% | +6.95% |
| CAGR | -51.02% | +6.96% | |
| Sharpe ratio | -0.41 | 0.32 | |
| Max drawdown | 78.06% | 52.75% | |
| Max daily drop | 16.03% | 9.60% | |
| Max wkly drop | 32.71% | 17.02% | |
| 5Y | Growth | +242.98% | -94.14% |
| CAGR | +27.99% | -43.35% | |
| Sharpe ratio | 0.66 | -0.63 | |
| Max drawdown | 78.88% | 97.14% | |
| Max daily drop | 34.63% | 40.15% | |
| Max wkly drop | 39.06% | 43.25% | |
| 10Y | Growth | +186.63% | -49.80% |
| CAGR | +16.59% | -6.66% | |
| Sharpe ratio | 0.52 | 0.12 | |
| Max drawdown | 87.29% | 98.48% | |
| Max daily drop | 34.63% | 40.15% | |
| Max wkly drop | 39.06% | 43.25% |
| Category | HIMS | TDOC |
|---|---|---|
| Company | HIMS | TDOC |
| Sector | N/A | N/A |
| Industry | N/A | N/A |
| Core business | N/A | N/A |
| Investor focus | N/A | N/A |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.